Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (261-270 of 337) with videos related to

Pageof 34
Sort By:
Therapeutic Drug Monitoring|December 31, 2010
Ribavirin plasma concentration measurements in patients with hepatitis C: early ribavirin concentrations predict steady-state concentrationsSerena Slavenburg, Hanneke W H A Huntjens-Fleuren, Ton S M Dofferhoff, et al.
Antiviral Therapy|April 28, 2006
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005)Mark A Boyd, Preeyaporn Srasuebkul, Mana Khongphattanayothin, et al.
Antiviral Therapy|January 25, 2006
Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosisReshma S Autar, Ferdinand W N M Wit, Jongkol Sankote, et al.
AIDS (London, England)|July 17, 2007
Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patientsReshma Saskia Autar, Ferdinand W N M Wit, Jongkol Sankote, et al.
Tuberculosis (Edinburgh, Scotland)|December 20, 2015
Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transportersLindsey H M Te Brake, Frans G M Russel, Jeroen J M W van den Heuvel, et al.
AIDS (London, England)|November 22, 2012
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant womenAngela P H Colbers, David A Hawkins, Andrea Gingelmaier, et al.
Clinics and Research in Hepatology and Gastroenterology|February 13, 2016
Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment: Results from a randomized controlled trial using real-time medication monitoringLotte G van Vlerken, Faydra I Lieveld, Suzanne van Meer, et al.
Pediatric Transplantation|March 1, 2016
Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patientsLisa C Martial, Bart A W Jacobs, Elisabeth A M Cornelissen, et al.
Targeted Oncology|April 13, 2018
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort StudyLotte M Knapen, Rutger H T Koornstra, Johanna H M Driessen, et al.
Journal of Hepatology|November 27, 2018
Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoringMinou van Seyen, Elise J Smolders, Peter van Wijngaarden, et al.
Pageof 34

Showing results (261-270 of 337) with videos related to

Sort By:
Pageof 34
Therapeutic Drug Monitoring|December 31, 2010
Ribavirin plasma concentration measurements in patients with hepatitis C: early ribavirin concentrations predict steady-state concentrationsSerena Slavenburg, Hanneke W H A Huntjens-Fleuren, Ton S M Dofferhoff, et al.
Antiviral Therapy|April 28, 2006
Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005)Mark A Boyd, Preeyaporn Srasuebkul, Mana Khongphattanayothin, et al.
Antiviral Therapy|January 25, 2006
Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosisReshma S Autar, Ferdinand W N M Wit, Jongkol Sankote, et al.
AIDS (London, England)|July 17, 2007
Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patientsReshma Saskia Autar, Ferdinand W N M Wit, Jongkol Sankote, et al.
Tuberculosis (Edinburgh, Scotland)|December 20, 2015
Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transportersLindsey H M Te Brake, Frans G M Russel, Jeroen J M W van den Heuvel, et al.
AIDS (London, England)|November 22, 2012
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant womenAngela P H Colbers, David A Hawkins, Andrea Gingelmaier, et al.
Clinics and Research in Hepatology and Gastroenterology|February 13, 2016
Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment: Results from a randomized controlled trial using real-time medication monitoringLotte G van Vlerken, Faydra I Lieveld, Suzanne van Meer, et al.
Pediatric Transplantation|March 1, 2016
Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patientsLisa C Martial, Bart A W Jacobs, Elisabeth A M Cornelissen, et al.
Targeted Oncology|April 13, 2018
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort StudyLotte M Knapen, Rutger H T Koornstra, Johanna H M Driessen, et al.
Journal of Hepatology|November 27, 2018
Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoringMinou van Seyen, Elise J Smolders, Peter van Wijngaarden, et al.
Pageof 34